Patent · US Expired

Derivatives of porphycene for photodynamic therapy of cancer

US5244671A · kind A · utility

12Cited by

11References

19Claims

0Family size

Assignee

Cytopharm, Inc. · US

Inventors

Emanuel Vogel · Cologne, DE
Peter Koch · Frankfurt, DE
Afssaneh Rahbar · Frechen, DE
Alexander D. Cross · Atherton, US

Key dates

Filing date	Jan 29, 1991
Grant date	Sep 14, 1993
Priority date	—
Expiry date	Jan 29, 2011

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

New porphycene compounds useful as photodynamic therapy agents. The porphycene compounds have an active group capable of binding to proteins and peptides and facilitating decomposition of the porphycenes following therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.